Clinical News

BSG statement on "Use of intravenous Hyoscine Butylbromide (Buscopan) during Gastrointestinal Endoscopy"

Tuesday, 04 April 2017 11:02

The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease.

Buscopan is commonly used during endoscopic procedures. It induces smooth muscle relaxation and reduces spasm in the gastrointestinal tract. It is used during upper GI Endoscopy and small bowel enteroscopy to reduce contraction and aid mucosal visualisation. During endoscopic retrograde cholangiopancreatography, it is used to facilitate access to the common bile duct during cannulation of the Ampulla of Vater. During colonoscopy, it is used to reduce haustral definition to optimise mucosal visualisation and lesion detection.

 

'FIT for symptomatic patients' workshop - NHSE in partnership with the BSG and ACPGBI

Tuesday, 04 April 2017 09:20

NHSE in partnership with BSG and ACPGBI ran a workshop on the 8th March, with clinicians from across the colorectal pathway, to scope activity and opinions on the potential use of FIT in symptomatic patients. Discussions focused on: what data collection was ongoing already, what the gaps were in our knowledge of FIT, and how clinicians could work collaboratively to fill the gaps in a timely manner. If you would like to find out more please see the summary of the meeting on the website, or contact Sophie Lumley at NHS England This e-mail address is being protected from spambots. You need JavaScript enabled to view it . We are interested to hear about other projects that are either ongoing (as research or service evaluation) or currently in the planning stages, or hear from areas interested in collecting data on FIT in symptomatic patients.

UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care

Thursday, 23 February 2017 11:47

Alenka J Brooks, Philip J Smith, Richard Cohen, Paul Collins, Andrew Douds, Valda Forbes, Daniel R Gaya, Brian T Johnston, Patrick J McKiernan Charles D Murray, Shaji Sebastian, Monica Smith, Lisa Whitley, Lesley Williams, Richard K Russell, Sara A McCartney, James O Lindsay

ABSTRACT

The risks of poor transition include delayed and inappropriate transfer that can result in disengagement with healthcare. Structured transition care can improve control of chronic digestive diseases and long-term health-related outcomes. These are the first nationally developed guidelines on the transition of adolescent and young persons (AYP) with chronic digestive diseases from paediatric to adult care. They were commissioned by the Clinical Services and Standards Committee of the British Society of Gastroenterology under the auspices of the Adolescent and Young Persons (A&YP) Section. Electronic searches for English-language articles were performed with keywords relating to digestive system diseases and transition to adult care in the Medline (via Ovid), PsycInfo (via Ovid), Web of Science and CINAHL databases for studies published from 1980 to September 2014. The quality of evidence and grading of recommendations was appraised using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. The limited number of studies in gastroenterology and hepatology required the addition of relevant studies from other chronic diseases to be included.

These guidelines deal specifically with the transition of AYP living with a diagnosis of chronic digestive disease and/or liver disease from paediatric to adult healthcare under the following headings;

  1. Patient populations involved in AYP transition
  2. Risks of failing transition or poor transition
  3. Models of AYP transition
  4. Patient and carer/parent perspective in AYP transition
  5. Surgical perspective
 

Thanksgiving service for Dr Basil C Morson

Wednesday, 22 February 2017 12:47

A service of thanksgiving will be held on Tuesday 2 May 2017 at 10.30 am at St James' Church, Spanish Place in London to commemorate the life and works of Dr Basil C Morson.

All are welcome to attend. Please indicate your intention to attend this Service, which will be fully choral with the Choir of St James' Church with Iestyn Evans, Director of Music to - This e-mail address is being protected from spambots. You need JavaScript enabled to view it (Subject - BCM Service)

This Service precedes the Scientific Meeting The Past, Present and Future of Colorectal Cancer: The Legacy of Dr Basil C Morson to be held later on 2 May 2017 at The Royal Society of Medicine from 1.00 pm.

Further details may be obtained from the RSM:
Tel - 020 7290 3941
Email - This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Page 6 of 16